The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma

The heat shock transcription factor 1 (HSF1) has recently been reported to promote malignant transformation and growth. Here we provide experimental evidence for a role of HSF1 in the pathogenesis of multiple myeloma (MM). Immunohistochemical analyses revealed that HSF1 was overexpressed in half of...

Full description

Saved in:
Bibliographic Details
Main Authors: Heimberger, Tanja (Author) , Andrulis, Mindaugas (Author)
Format: Article (Journal)
Language:English
Published: 2013
In: British journal of haematology
Year: 2013, Volume: 160, Issue: 4, Pages: 465-476
ISSN:1365-2141
DOI:https://doi.org/10.1111/bjh.12164
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/https://doi.org/10.1111/bjh.12164
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.12164
Get full text
Author Notes:Tanja Heimberger, Mindaugas Andrulis, Simone Riedel, Thorsten Stühmer, Heike Schraud, Andreas Beilhack, Thomas Bumm, Bjarne Bogen, Hermann Einsele, Ralf C. Bargou and Manik Chatterjee

MARC

LEADER 00000caa a2200000 c 4500
001 1750110660
003 DE-627
005 20220819123248.0
007 cr uuu---uuuuu
008 210302s2013 xx |||||o 00| ||eng c
024 7 |a 10.1111/bjh.12164  |2 doi 
035 |a (DE-627)1750110660 
035 |a (DE-599)KXP1750110660 
035 |a (OCoLC)1341396582 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Heimberger, Tanja  |d 1981-  |e VerfasserIn  |0 (DE-588)1043405046  |0 (DE-627)770519547  |0 (DE-576)394776402  |4 aut 
245 1 4 |a The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma  |c Tanja Heimberger, Mindaugas Andrulis, Simone Riedel, Thorsten Stühmer, Heike Schraud, Andreas Beilhack, Thomas Bumm, Bjarne Bogen, Hermann Einsele, Ralf C. Bargou and Manik Chatterjee 
246 3 0 |a one 
264 1 |c 2013 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 18 December 2012 
500 |a Gesehen am 08.10.2021 
520 |a The heat shock transcription factor 1 (HSF1) has recently been reported to promote malignant transformation and growth. Here we provide experimental evidence for a role of HSF1 in the pathogenesis of multiple myeloma (MM). Immunohistochemical analyses revealed that HSF1 was overexpressed in half of the investigated MM samples, including virtually all cases with extramedullary manifestations or anaplastic morphology. HSF1 function was inhibited either by siRNA-mediated knockdown or pharmacologically through treatment with triptolide. Both approaches caused depletion of HSF1, lowered the constitutively high expression of a multitude of protective HSPs (such as HSP90, HSP70, HSP40 and HSP27), induced apoptosis in human MM cells in vitro, and strongly reduced MM tumour growth in vivo. Furthermore, we observed that treatment-induced upregulation of HSPs after proteasome or HSP90 inhibition was critically dependent on HSF1. Importantly, the apoptotic effects of the HSP90 inhibitor NVP-AUY922 or the proteasome inhibitor bortezomib were strongly enhanced in combination with triptolide, suggesting a salvage role of HSF1-dependent HSP induction in response to drug treatment. Collectively, our data indicate that inhibition of HSF1 affects multiple protective HSPs and might therefore represent a therapeutic strategy - in particular in combination with proteasome or HSP90 inhibitors. 
650 4 |a apoptosis 
650 4 |a heat shock proteins 
650 4 |a multiple myeloma 
650 4 |a oncogenic signalling 
700 1 |a Andrulis, Mindaugas  |d 1972-  |e VerfasserIn  |0 (DE-588)131682172  |0 (DE-627)512716587  |0 (DE-576)298670534  |4 aut 
773 0 8 |i Enthalten in  |t British journal of haematology  |d Oxford [u.a.] : Wiley-Blackwell, 1955  |g 160(2013), 4, Seite 465-476  |h Online-Ressource  |w (DE-627)269758941  |w (DE-600)1475751-5  |w (DE-576)09113997X  |x 1365-2141  |7 nnas  |a The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma 
773 1 8 |g volume:160  |g year:2013  |g number:4  |g pages:465-476  |g extent:12  |a The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma 
856 4 0 |u https://doi.org/https://doi.org/10.1111/bjh.12164  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.12164  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210302 
993 |a Article 
994 |a 2013 
998 |g 131682172  |a Andrulis, Mindaugas  |m 131682172:Andrulis, Mindaugas  |d 910000  |d 912000  |e 910000PA131682172  |e 912000PA131682172  |k 0/910000/  |k 1/910000/912000/  |p 2 
999 |a KXP-PPN1750110660  |e 3879892067 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1750110660","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["First published: 18 December 2012","Gesehen am 08.10.2021"],"title":[{"title_sort":"heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma","title":"The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma"}],"person":[{"family":"Heimberger","given":"Tanja","roleDisplay":"VerfasserIn","display":"Heimberger, Tanja","role":"aut"},{"display":"Andrulis, Mindaugas","roleDisplay":"VerfasserIn","role":"aut","family":"Andrulis","given":"Mindaugas"}],"relHost":[{"title":[{"subtitle":"BJHaem : an official journal of the British Society for Haematology","title":"British journal of haematology","title_sort":"British journal of haematology"}],"recId":"269758941","language":["eng"],"corporate":[{"role":"isb","display":"British Society for Haematology","roleDisplay":"Herausgebendes Organ"},{"roleDisplay":"Herausgebendes Organ","display":"European Hematology Association","role":"isb"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The heat shock transcription factor 1 as a potential new therapeutic target in multiple myelomaBritish journal of haematology","note":["Gesehen am 08.05.08"],"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"part":{"text":"160(2013), 4, Seite 465-476","volume":"160","extent":"12","year":"2013","issue":"4","pages":"465-476"},"pubHistory":["1.1955 -"],"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"id":{"eki":["269758941"],"doi":["10.1111/(ISSN)1365-2141"],"zdb":["1475751-5"],"issn":["1365-2141"]},"origin":[{"dateIssuedDisp":"1955-","dateIssuedKey":"1955","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"12 S."}],"id":{"doi":["10.1111/bjh.12164"],"eki":["1750110660"]},"origin":[{"dateIssuedDisp":"2013","dateIssuedKey":"2013"}],"name":{"displayForm":["Tanja Heimberger, Mindaugas Andrulis, Simone Riedel, Thorsten Stühmer, Heike Schraud, Andreas Beilhack, Thomas Bumm, Bjarne Bogen, Hermann Einsele, Ralf C. Bargou and Manik Chatterjee"]}} 
SRT |a HEIMBERGERHEATSHOCKT2013